Stemline Therapeutics Inc (NASDAQ:STML)

17.45
Delayed Data
As of 12:39pm ET
 +0.25 / +1.45%
Today’s Change
7.30
Today|||52-Week Range
18.75
+11.86%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2014

2015

2016

2017
Operating ActivitiesNet Income / Starting Line-28.8M-37.2M-38.3M-67.8M
 
 
 
 
 
Depreciation153.3K153.8K80.3K14.6K
 
 
 
 
 
Total Other Cash Flow4.7M5.5M7.7M8.8M
 
 
 
 
 
Funds From Operations-24.0M-31.6M-30.5M-59.0M
 
 
 
 
 
Funds From/For Other Operating Expenses1.7M-6.0M-441.2K-9.4M
 
 
 
 
 
Net Cash Flow - Operating Activities-25.7M-25.6M-30.1M-49.6M
 
 
 
 
 
 
InvestingIncrease In Investments-16.2M-105.6M-26.5M-61.9M
 
 
 
 
 
Decrease In Investments22.6M54.7M53.1M57.6M
 
 
 
 
 
Capital Expenditures0.00-19.5K-7.1K-128.8K
 
 
 
 
Net Cash Flow Investing6.4M-50.9M26.7M-4.4M
 
 
 
 
 
 
FinancingShort Term Borrowings0.000.000.000.00--
Long Term Borrowings0.000.000.000.00--
Long Term Debt Reduction0.000.000.000.00--
Net Proceeds Stock Sale135.3K64.9M355.8K48.5M
 
 
 
 
 
Common Preferred Redeemed0.000.000.000.00--
Common Dividends0.00----0.00--
Cash Dividends Paid - Total0.00----0.00--
Other Sources - Financing0.000.000.000.00--
Other Uses - Financing0.000.000.000.00--
Net Cash Flow - Financing135.3K64.9M355.8K48.5M
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash0.00--------
 
Net Change In Cash-19.2M-11.6M-3.1M-5.5M